97 related articles for article (PubMed ID: 17206130)
1. A 'good death' for tumor immunology.
Storkus WJ; Falo LD
Nat Med; 2007 Jan; 13(1):28-30. PubMed ID: 17206130
[No Abstract] [Full Text] [Related]
2. Calreticulin exposure increases cancer immunogenicity.
Clarke C; Smyth MJ
Nat Biotechnol; 2007 Feb; 25(2):192-3. PubMed ID: 17287754
[No Abstract] [Full Text] [Related]
3. Calreticulin exposure dictates the immunogenicity of cancer cell death.
Obeid M; Tesniere A; Ghiringhelli F; Fimia GM; Apetoh L; Perfettini JL; Castedo M; Mignot G; Panaretakis T; Casares N; Métivier D; Larochette N; van Endert P; Ciccosanti F; Piacentini M; Zitvogel L; Kroemer G
Nat Med; 2007 Jan; 13(1):54-61. PubMed ID: 17187072
[TBL] [Abstract][Full Text] [Related]
4. Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis.
Obeid M; Panaretakis T; Joza N; Tufi R; Tesniere A; van Endert P; Zitvogel L; Kroemer G
Cell Death Differ; 2007 Oct; 14(10):1848-50. PubMed ID: 17657249
[No Abstract] [Full Text] [Related]
5. The key role of calreticulin in immunomodulation induced by chemotherapeutic agents.
Yamamura Y; Tsuchikawa T; Miyauchi K; Takeuchi S; Wada M; Kuwatani T; Kyogoku N; Kuroda A; Maki T; Shichinohe T; Hirano S
Int J Clin Oncol; 2015 Apr; 20(2):386-94. PubMed ID: 24972573
[TBL] [Abstract][Full Text] [Related]
6. [Calreticulin dictates the immunogenicity of anti-cancer chemotherapy and radiotherapy].
Apetoh L; Ghiringhelli F; Zitvogel L
Med Sci (Paris); 2007 Mar; 23(3):257-8. PubMed ID: 17349284
[No Abstract] [Full Text] [Related]
7. Witch hunt against tumor cells enhanced by dendritic cells.
Locher C; Rusakiewicz S; Tesnière A; Ghiringhelli F; Apetoh L; Kroemer G; Zitvogel L
Ann N Y Acad Sci; 2009 Sep; 1174():51-60. PubMed ID: 19769736
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference.
Chaput N; De Botton S; Obeid M; Apetoh L; Ghiringhelli F; Panaretakis T; Flament C; Zitvogel L; Kroemer G
J Mol Med (Berl); 2007 Oct; 85(10):1069-76. PubMed ID: 17891368
[TBL] [Abstract][Full Text] [Related]
9. Ecto-calreticulin in immunogenic chemotherapy.
Obeid M; Tesniere A; Panaretakis T; Tufi R; Joza N; van Endert P; Ghiringhelli F; Apetoh L; Chaput N; Flament C; Ullrich E; de Botton S; Zitvogel L; Kroemer G
Immunol Rev; 2007 Dec; 220():22-34. PubMed ID: 17979837
[TBL] [Abstract][Full Text] [Related]
10. [Effects of Geranium sibirum extracts on liver metastases in nude mice with colonic cancer].
Huang GD; You Y; Huang YH; Tang LJ; Yang ZF; Xu L; Huang DF; Xiao MZ
Zhong Yao Cai; 2009 Jan; 32(1):97-9. PubMed ID: 19445132
[TBL] [Abstract][Full Text] [Related]
11. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
12. Immunogenic cancer cell death: a key-lock paradigm.
Tesniere A; Apetoh L; Ghiringhelli F; Joza N; Panaretakis T; Kepp O; Schlemmer F; Zitvogel L; Kroemer G
Curr Opin Immunol; 2008 Oct; 20(5):504-11. PubMed ID: 18573340
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system.
Ciampricotti M; Hau CS; Doornebal CW; Jonkers J; de Visser KE
Nat Med; 2012 Mar; 18(3):344-6; author reply 346. PubMed ID: 22395693
[No Abstract] [Full Text] [Related]
15. Gold (III) porphyrin complexes induce apoptosis and cell cycle arrest and inhibit tumor growth in colon cancer.
Tu S; Wai-Yin Sun R; Lin MC; Tao Cui J; Zou B; Gu Q; Kung HF; Che CM; Wong BC
Cancer; 2009 Oct; 115(19):4459-69. PubMed ID: 19572413
[TBL] [Abstract][Full Text] [Related]
16. [Effect of potassium iodide on tumor growth].
Aleksander SK; Fidler LM; Revazova ES; Borisov VI
Biull Eksp Biol Med; 1991 Jan; 111(1):64-6. PubMed ID: 2054478
[TBL] [Abstract][Full Text] [Related]
17. Specific demonstration of drug-induced tumour cell apoptosis in human xenografts models using a plasma biomarker.
Olofsson MH; Cummings J; Fayad W; Brnjic S; Herrmann R; Berndtsson M; Hodgkinson C; Dean E; Odedra R; Wilkinson RW; Mundt KE; Busk M; Dive C; Linder S
Cancer Biomark; 2009; 5(3):117-25. PubMed ID: 19407366
[TBL] [Abstract][Full Text] [Related]
18. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
Zhou YL; Hu WX; Lü YP; Qiu LN; Wang WS; Yang ZY; Liu JD; Rao GW
Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
Zhang ZM; Yang XY; Deng SH; Xu W; Gao HQ
Chin Med J (Engl); 2007 Aug; 120(15):1336-42. PubMed ID: 17711740
[TBL] [Abstract][Full Text] [Related]
20. Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination.
Kim SG; Park MY; Kim CH; Sohn HJ; Kim HS; Park JS; Kim HJ; Oh ST; Kim TG
Vaccine; 2008 Nov; 26(50):6433-40. PubMed ID: 18812201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
